Technology / Scientific & Technical InstrumentsNasdaqGM
$0.70
+0.00 (+0.00%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 26% · confianza 25%
FCF escenarios
weak_data · normalized FCF $-5.5M · quality 50.7/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
3/100
F
Piotroski
2/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
8/100
SEC 0%
Sin guardar todavía.
Market Cap
$34M
P/E
N/A
•EV/EBITDA
N/A
•ROE
-518.1%
↓Gross Margin
N/A
•Debt/Equity
N/A
•Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2024–2025 · 1 años de histórico normalizado
Revenue CAGR
—
FCF CAGR
—
FCF margin
-7725.0%
FCF / Net income
0.68x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $113250.0 · net income $-12.8M · FCF $-8.7M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 |
|---|---|---|---|
| Income Statement | |||
| Revenue | $113250.00 | $113250.00 | — |
| Net Income | $-12.8M | $-12.8M | $-4.5M |
| EPS | -0.40 | -0.40 | -0.16 |
| Net Margin | -11325.7% | -11325.7% | — |
| Cash Flow | |||
| Free Cash Flow | $-8.7M | $-8.7M | $-2.3M |
| Returns | |||
| ROE | -518.1% | -518.1% | 461.6% |
| Growth & Yield | |||
| EPS Growth | -150.0% | -150.0% | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Unavailable: positive start/end prices are required.